PT Kalbe Farma Tbk.
PTKFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $70,611,195,863 | $72,990,824,328 | $123,083,504,429 | $75,275,023,499 |
| - Cash | $4,723,293,839 | $3,232,420,597 | $3,949,768,855 | $6,216,247,802 |
| + Debt | $559,222,105 | $618,538,351 | $1,167,717,692 | $626,155,103 |
| Enterprise Value | $66,447,124,129 | $70,376,942,083 | $120,301,453,266 | $69,684,930,800 |
| Revenue | $32,627,776,108 | $30,449,134,078 | $28,933,502,647 | $26,261,194,512 |
| % Growth | 7.2% | 5.2% | 10.2% | – |
| Gross Profit | $12,957,040,192 | $11,551,488,981 | $11,704,066,436 | $11,283,784,241 |
| % Margin | 39.7% | 37.9% | 40.5% | 43% |
| EBITDA | $4,614,036,522 | $4,432,825,910 | $5,246,054,530 | $4,874,458,672 |
| % Margin | 14.1% | 14.6% | 18.1% | 18.6% |
| Net Income | $3,240,636,626 | $2,766,748,040 | $3,382,209,769 | $3,183,621,310 |
| % Margin | 9.9% | 9.1% | 11.7% | 12.1% |
| EPS Diluted | 70.22 | 59.81 | 72.71 | 67.92 |
| % Growth | 17.4% | -17.7% | 7.1% | – |
| Operating Cash Flow | $4,785,179,041 | $2,907,475,171 | $3,769,449,699 | $2,825,946,276 |
| Capital Expenditures | -$1,250,335,290 | -$1,178,972,215 | -$870,099,808 | -$1,000,869,590 |
| Free Cash Flow | $3,534,843,752 | $1,728,502,956 | $2,899,349,891 | $1,825,076,686 |